Pediatric rheumatology

The impact of time to diagnosis on health service use, cost, and quality of life for patients with juvenile idiopathic arthritis: a cost-utility analysis

Pediatr Rheumatol Online JPublished Cost-utility analysis

Authors' conclusion

Interventions to improve the time to diagnosis of JIA within six months are likely cost-effective and can significantly improve HRQoL for people living with JIA.

Study context

Population
Children with Juvenile Idiopathic Arthritis (JIA); healthcare use and time to diagnosis from The IMPACT Survey, Australia
Participants
163 children
Comparison
Time from actively seeking treatment to formal diagnosis of JIA: < 6 months vs 6 + months
  • 6 + monthsn = 61reference
Outcome
Health service use, HRQoL (CHU9D) and associated healthcare costs; incremental QALYs
Follow-up
Lifetime
Methodological detailslifetime horizon, health funder perspective, 2023 Australian dollars, costs and Quality Adjusted Life Years (QALYs) present valued at 5% per annum, sensitivity analyses
  • Lifetime horizon
  • Health funder perspective
  • 2023 Australian dollars
  • Costs and QALYs present valued at 5% per annum
  • Sensitivity analyses

Main finding

As reported in the abstract

Lifetime healthcare cost savings, QALYs and net benefit per child, diagnosis within 6 months vs 6+ months

Present value of healthcare cost savings per child over a lifetime, timely diagnosis

$208,458

95%CI $45,388, $371,528

Additional QALYs per child over a lifetime from increased health-related quality of life (HRQoL)

2.82

95%CI 1.03, 4.61

Estimated net benefit to health funder per child at WTP $50,000 per QALY

$349,520

95%CI $139,630, $559,411

Further findings

HRQoL (CHU9D utility value), diagnosis within 6 months vs 6+ months

Significant increase in HRQoL utility value with timely diagnosis
0.14 (95%CI 0.05, 0.23)

Annual healthcare funder costs, diagnosis within 6 months vs 6+ months

Mean annual decrease in costs for the healthcare funder per child with diagnosis within 6 months
more than $10,000
Most cost savings from fewer hospitalizations for pain, inflammation and investigative procedures

Persistence of differences in health service use and HRQoL · 20 years from diagnosis

Differences from timely diagnosis persisted over 20 years from diagnosis

Original publication

The impact of time to diagnosis on health service use, cost, and quality of life for patients with juvenile idiopathic arthritis: a cost-utility analysis. Pediatr Rheumatol Online J. Published 24 February 2026. doi:10.1186/s12969-026-01195-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.